
Anti-Cyclin D1 Picoband antibody, PB9370, Western blotting All lanes: Anti Cyclin D1 (PB9370) at 0.5ug/ml Lane 1: Human Placenta Tissue Lysate at 50ug Lane 2: HELA Whole Cell Lysate at 40ug Lane 3: 293T Whole Cell Lysate at 40ug Predicted bind size: 33KD Observed bind size: 33KD
Anti-Cyclin D1/CCND1 Antibody Picoband(r)
PB9370
Overview
- SupplierBoster Bio
- Product NameAnti-Cyclin D1 Picoband Antibody
- Delivery Days Customer9
- Application Supplier NoteWB: The detection limit for Cyclin D1 is approximately 0.1ng/lane under reducing conditions. Tested Species: In-house tested species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration500 ug/ml
- Gene ID595
- Target nameCCND1
- Target descriptioncyclin D1
- Target synonymsB-cell CLL/lymphoma 1; B-cell lymphoma 1 protein; BCL1; BCL-1 oncogene; D11S287E; G1/S-specific cyclin-D1; PRAD1; PRAD1 oncogene; U21B31
- HostRabbit
- IsotypeIgG
- Protein IDP24385
- Protein NameG1/S-specific cyclin-D1
- Scientific DescriptionBoster Bio Anti-Cyclin D1/CCND1 Antibody Picoband® catalog # PB9370. Tested in WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203
References
- Rutaecarpine Ameliorates Murine N-Methyl-N-Nitro-N-Nitrosoguanidine-Induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway.Read more
- CRP-1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial-mesenchymal transition and Wnt/beta-catenin signaling.Read more
- DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression.Read more
- Circ-EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/beta-catenin pathway through the miR-1253/NOVA2 axis.Read more
- Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer.Read more
- SIRT6 Promotes the Progression of Prostate Cancer via Regulating the Wnt/beta-Catenin Signaling Pathway.Read more
- Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/beta-Catenin Signaling Pathway.Read more
- Regulation of the PTEN/PI3K/AKT pathway in RCC using the active compounds of natural products in vitro.Read more
- Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer.Read more
- The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT Pathway. Sanches JGP et al., 2021, Front OncolRead more